Detection Technology: Security strength adds to earnings - Evli

Detection Technology: DT’s Q1 didn’t contain many surprises other than MBU being weaker and SBU stronger than expected. We estimate EBITA margin to be headed above 15% as growth continues. Evli

Publicerad: 2024-04-26 10:49 av Evli Research

Prolight Diagnostics: Bra slagläge för hjärtbiomarkörtest - Mangold

Prolight Diagnostics: Mangold Insight inleder bevakning av medicinteknik-bolaget Prolight Diagnostics med rekommendationen Köp. Riktkursen sätts till 1,05 kronor per aktie på 12 månaders sikt. Bolaget utvecklar ett patientnära analyssystem, även kallat Point-of-Care (POC), med produktnamnet Psyros. POC-system utgör en kr ...

Publicerad: 2024-04-26 10:48 av Mangold Insight

Exel Composites: Positioning for volume recovery - Evli

Exel Composites: Exel’s Q1 results remained quite weak, although q/q improvement continued. Exel has been finding efficiency gains and positioning itself for a recovery in volumes. We expect EBIT to climb back to black soon, but more significant gains may not arrive before H2. Evli

Publicerad: 2024-04-26 10:45 av Evli Research

ANALYS Fastpartner: Ser mer positiva signaler på hyresmarknaden

Fastpartner: Hyresmarknaden förbättrades under kvartalet, vilket spelar Fastpartner rakt i händerna. Idag handlas bolagets aktie till en betydande rabatt. Vi höjer motiverat värde till 87 kr (tidigare 80). Väsentligt fler lokalförfrågningar under Q1Fastpartners hyresintäkter ökade under Q1 med 4,1% till 578,9 mk ...

Publicerad: 2024-04-26 10:45 av Analysguiden

Dovre Group: Renewables construction picks up - Evli

Dovre Group: Dovre Q1 EBIT, excluding the write-off, was a bit below our estimate but we raise our Renewable Energy estimates for the rest of the year. Our FY ’25 estimates are almost intact. Evli

Publicerad: 2024-04-26 10:44 av Evli Research

SRV Group: Moving in the right direction - Evli

Non-residential volumes supported the profitability in Q1/24 as we had expected. Non-residential will remain in the driver’s seat especially for 2024E while we estimate residential to start contributing slowly during 2025E. Evli

Publicerad: 2024-04-26 10:43 av Evli Research

Alcadon Group Q1: Weaker on growth, underlying EBITA 9% ahead - SEB

Alcadon Group: In all, net sales are 2% below our estimate and 3% below consensus. Organic growth is 1% y/y (SEBE: +6%). Reported EBITA of SEK 21m is 12% below our estimate. As earnings include non-realised FX losses on contingency debt (earn-outs) of SEK 5m, our initial take is that underlying EBITA came in at SE ...

Publicerad: 2024-04-26 10:20 av SEB Research

Nelly Group Q1: What is there not to like - strategic shift playing out - SEB

Nelly Group: Nelly Group reports Q1 sales at SEK 222m - 5% ahead of our estimates. Gross margins shine, improving 8.2pp y/y to 49.1% (4.5pp above our 44.6% estimate). From cost management and efficiency gains (automated DC), SG&A-to-sales are down 4.7pp y/y to 48.5%. EBIT of SEK 1m compares to our LBIT forecast ...

Publicerad: 2024-04-26 10:19 av SEB Research

Iconovo - Rapport utan överraskningar

Iconovo: Q1(24) i korthetNettoomsättningen under Q1(24) uppgick till 1,7 mkr (0,3) och övriga rörelseintäkter uppgick till 0,8 mkr (2,7). Den lägre nivån på rörelseintäkterna beror på lägre projektbidrag jämfört med samma period under föregående år, då ett större projektbidrag från Bill & Melinda Gates Found ...

Publicerad: 2024-04-26 10:00 av Penser Access

ANALYS SinterCast: Första kvartalet 2024

SinterCast: Sintercast redovisade en positiv start på året och dubblade kassaflödet i kvartalet. Marknadens negativa reaktion är enligt oss obefogad och motiverat värde justeras till 150 kronor. SinterCast dubblar kassaflödet i kvartaletSintercast redovisar en positiv start på året med en volymtillväxt på 18 pr ...

Publicerad: 2024-04-26 10:00 av Analysguiden

30 estimat inför Bredband2s rapport

Bredband2: Inför Bredband2s rapport (6 maj) förväntar sig investerare på Pinpoint Estimates omsättning och resultat inom följande viktade intervall:Nettoomsättning: 405,1 - 413,2 MSEKEBIT: 31,71 - 34,53 MSEKDatan baseras på estimat från 30 investerare.Pinpoint Estimates är en öppen plattform som sammanställer ...

Publicerad: 2024-04-26 09:49 av Pinpoint Estimates

Intervju med Sileon- Carnegie Investment Bank - 26 april 2024

Sileon: I denna intervju berättar Sileons VD David Larsson om bolagets slutgiltiga transformation till ett renodlat techbolag inom finanssektorn, varför intäkterna steg markant i Q1 och vilken den första bankkunden är. Se intervjun på Penser Play: https://youtu.be/SJ5zP-2RkVwDetta är en betald analys från C ...

Publicerad: 2024-04-26 09:32 av Penser Future

Intervju med Nivika Fastigheter- Carnegie Investment Bank - 26 april 2024

Nivika Fastigheter: Aktieanalytiker Mathias Carlson intervjuar VD och grundare Niclas Bergman efter publicerad Q2-rapport (dec-feb). De diskuterar huvudpunkter från perioden, nyckeln till framgång i den lokala marknaden, möjligheterna med en stor kassa och starka finanser och vad som är unikt med bolagets investment ca ...

Publicerad: 2024-04-26 09:10 av Penser Access

Integrum: CBPR operations suspended

Integrum: Carnegie has published a new flash comment on Integrum following recent news flow. To access the full report and subscribe to future updates, visit https://www.carnegie.se/en/commissioned-research/integrum/ InformationThis is a press release from Carnegie. For information about Carnegie commissioned ...

Publicerad: 2024-04-26 08:47 av Carnegie

Interview with Zwipe - Carnegie Investment Bank - April 25th, 2024

Zwipe: Equity analyst Markus Almerud interviews Zwipe's CEO Robert Puskaric after the company's operational update for Q1. They discuss the status of the biometric access card market, the progress with its partners, how the progress will flow through from the integrators to the end customer and how imprort ...

Publicerad: 2024-04-26 08:35 av Penser Access

B3 Consulting Group - Recovery still awaits

B3 Consulting Group: We lower '24e-'26e adj. EBITA by 35-1% Potential for utilisation improvement in H2'24 '24e-'25e EV/EBITA of 12-6x It's still tough out thereQ1 was undoubtedly a tough quarter for B3, and seemingly also for other IT consulting businesses. B3's sales and EBITA declined by 12% and 57% y-o-y, respective ...

Publicerad: 2024-04-26 08:32 av ABG Sundal Collier

Alcadon - Adj. EBITA in line

Alcadon Group: Adj. EBITA SEK 27.3m (-1% vs. ABGSCe 27.6m) Q1 numbers imply no material estimate revisions Trading at 9x '24e EV/EBITA on our pre-Q1 estimates Q1 outcomeSales were SEK 399m (-3% vs. ABGSCe 411m), up 3% y-o-y, of which +1% was organic growth (ABGSCe +4%). The gross margin was slightly lower than exp ...

Publicerad: 2024-04-26 08:31 av ABG Sundal Collier

CTT Systems - 16% EBIT beat on slightly lower sales

CTT Systems: Sales -5%, adj. EBIT +16% vs. ABGSCe, +5% org. sales Guides for Q2 sales growth of ~11%, could lift ets. 1-3% (ex FX) Slightly more cautious than expected, share has been strong YTD Q1 detailsStrong profitability while sales came in below CTT's own forecasts. Sales grew 5% organically (ABGSCe +10%) ...

Publicerad: 2024-04-26 08:31 av ABG Sundal Collier

Midsona - More efficiency on the horizon

Midsona: We raise '25e-'26e adj. EBIT by 1% Continued gross margin recovery expected Trading at '24e EV/adj. EBITA of ~10x The hard work is paying offThe Q1'24 numbers beat our estimates on sales and adj. EBIT by +3% and +17%, respectively. The company is actively discontinuing negative and low-margin SKUs a ...

Publicerad: 2024-04-26 08:30 av ABG Sundal Collier

Interview with Ependion - Carnegie Investment Bank - April 24th, 2024

Ependion: Equity analyst Markus Almerud interviews Ependion's CEO Jenny Sjödahl after its Q1 report. For Westermo they discuss general demand, the state of the largest train customer that has disorted sorder patterns for the entity in the past year, order levels in the end market segments outside of Train and ...

Publicerad: 2024-04-26 08:30 av Penser Access

Arcoma - Tillväxtmomentum drivet av fortsatt hög aktivitet i Nordamerika

Arcoma: Historiskt starkt Q1 understryker Nordamerikamomentum och ökade volymer för i5Omsättningen för Q1 uppgick till 46,5 mkr (37,6 mkr), motsvarande en stark tillväxt y/y om 24%. Geografiskt var tillväxten driven av Nordamerika, en tillväxt som är ett resultat av en god underliggande marknad men även par ...

Publicerad: 2024-04-26 08:00 av Penser Access

Rottneros - Produktionsstörningar tyngde Q1-resultatet

Rottneros: Bra leveranser, högre försäljningspriser, men kraftigt fall i produktionenQ1-resultatet påverkades kraftigt negativt av produktionsstörningar i Vallviks Bruk på grund av den stränga vinterkylan och vissa andra enskilda störningar. Produktionen föll med 15% y/y, vilket påverkade EBIT negativt med cir ...

Publicerad: 2024-04-26 08:00 av Penser Access

Pharma Equity Group (One-pager): Continues to move forward but the shares continues to slide.

Pharma Equity Group: Since the beginning of the year, Pharma Equity Group’s share price has fallen approximately 40 percent which is markedly lower than Biotech and Life Science stocks in general when using the S&P Biotech index as a proxy which is down just over 5 percent. The huge underperformance comes at a time even ...

Publicerad: 2024-04-26 08:00 av HC Andersen Capital via Inderes

Betssons rörelseresultat över förväntningarna

Betsson: Pinpointkonsensus inför Betssons Q1-rapport baseras på 140 estimat. Sammanställningen anges i MEUR.NettoomsättningPinpointkonsensus: 247,1Utfall: 248,2Diff: 0,43%EBITPinpointkonsensus: 51,73Utfall: 57,9Diff: 11,93%Pinpoint Estimates är en öppen plattform som sammanställer estimat från investerare oc ...

Publicerad: 2024-04-26 07:34 av Pinpoint Estimates

Consti: Onwards in a tough market - Evli

Consti: Consti’s Q1 net sales beat our estimates slightly while operative profitability missed by only a small margin. Order intake was on the softer side, yet backlog remains robust. Evli

Publicerad: 2024-04-26 07:02 av Evli Research

Bactiguard: Growth to return in Q2 - SEB

Bactiguard Holding: We leave our estimates largely unchanged after Q1. Our valuation range of SEK 61-81 per share is thus reiterated. Bactiguard grew sales in its Wound management portfolio in Q1 and as comps are easier for BD ahead, we believe growth may return at the group level, despite the BIP portfolio being phase ...

Publicerad: 2024-04-26 06:58 av SEB Research

CDON: In search of growth - SEB

CDON: As we suspected, CDON had a challenging start to the year, with 3P GMV at its core CDON marketplace down 24% y/y, burdened by weak site traffic following Google changing its search algorithms in Q4/23. Take rates and group GPAM continue up and management remains firm on its ongoing SEK 40m savings p ...

Publicerad: 2024-04-26 06:58 av SEB Research

Verkkokauppa: Tough going as consumers remain dispirited - SEB

Verkkokauppa.com: Verkkokauppa.com’s Q1 sales declined by 11.4% y/y, which highlights how tough the market is, but on a positive note the gross margin was up 70bp. The company is building its strength while it waits for consumers to return. Sales of own brands grew by 7% y/y and speed deliveries by 33% y/y. In absolu ...

Publicerad: 2024-04-26 06:58 av SEB Research

Actic: Sweat it out - SEB

Actic Group: Following Q1 results that were well ahead of our estimates, we raise our full-year forecasts for Actic Group to mainly reflect higher margins. While we now assume fewer gym clubs at year-end, we increase the impact of efficiency measures (members/club) and raise ARPM. In all, adding strong cost mana ...

Publicerad: 2024-04-26 06:57 av SEB Research

Projektengagemang: A margin story to start with - SEB

Projektengagemang Sweden: PE, the architectural consultancy group, reported Q1 earnings well ahead of all market estimates, as its cost savings programme bolstered its P&L lines. While we lower our sales forecasts, the reductions are more than offset by raised margin assumptions and we raise EBIT by an average of 7% for 2024 ...

Publicerad: 2024-04-26 06:57 av SEB Research